Boston Scientific (NYSE:BSX) announced today that it completed its previously announced acquisition of Nalu Medical.

BD (NYSE: BDX) today set the record date for the planned spin-off of its Biosciences & Diagnostics business to Waters ...

DMedical announced today that it raised more than $100 million (AU$150 million) through a new institutional placement.

Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.

Robocath announced today that it launched a first-in-human clinical study evaluating its new robotic system in coronary artery disease.

Outset Medical (Nasdaq: OM) announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.

Masimo (Nasdaq:MASI) has opposed an attempt by Apple to overturn the recent patent infringement ruling ordering it to pay $634 million.

Medtronic announced two new milestones for its Affera Sphere-360 catheter for pulsed field ablation (PFA) procedures.

Penumbra (NYSE:PEN) announced today that it launched the Lightning Flash 3.0 computer-assisted vacuum thrombectomy (CAVT) ...

The FDA issued an early alert after Olympus issued a letter recommending the removal of certain High Flow Insufflation Units.

Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.

HighLife announced today that it received CE mark approval for its transcatheter mitral valve replacement (TMVR) system.